: DzNep (EZH2) treatment has no effect on pri-miR-22 expression. Malignant CTCL cell line, MyLa2059, was treated for 24 hours with 1, 5 or 10µM DzNep or DMSO control. Relative expression of pri-miR-22 and 18S was determined by qPCR, reference GAPDH. Error bars reflect variation in technical triplicates.
Supplementary
: Down-regulation of putative miR-22 target genes following extra-corporeal photopherese (ECP). Putative miR-22 target genes were identified using three miRNA target prediction algorithms as indicated (A).Putative targets identified by at least three algoritms (indicated in yellow) or functionally validated were selected for further analysis (B). The expression of the high confidence predicted miR-22 validated targets (614 genes) was examined in microarray data from cells derived from CTCL patients pre-and post-ECP obtained from NCBI (GSE23604) [74] . Raw microarray data was analysed using the BRBArrayTool developed by Dr. Richard and the BRB-ArrayTools Developments Team. A subset of miR-22 target genes (74 genes) were significantly altered following ECP (<2 fold change, p< 0.001), including NCoA1 and PTEN (C and D). The expression of the validated miR-22 targets examined in the current study are shown (E).
